NVDA at $202.78 is a range-bound transition stock with a binary catalyst in 6 weeks (Q2 FY27 print on August 27). The "compressed valuation" thesis is real on math but mathematically contingent on SemiAnalysis's $203B H2 FY27 data-center estimate validating — a 20% gap to consensus that the market is treating as consensus without verification. The 14% drawdown from $235.74 has cleaned positioning, but it has not changed the underlying business: still exceptional, still structurally monopolistic, still hostage to Taiwan. The asymmetry the bulls cite (PEG 0.6, forward 16x on 42% growth) exists only if SemiConfirmation materializes. Without it, forward P/E re-expands to 20–22x on flatlining estimates — not "cheap."
Marginally attractive on relative basis, neutral on absolute basis. Forward 16x is anomalous for a 40%+ grower, but the multiple is SemiConfirmation-priced, not the actual consensus EPS. The market is paying for the trajectory, not the print.
Roughly balanced with downside convexity. Bull case +38% (SemiConfirmation + China reopen + sovereign AI inflection), bear case -24% (cycle digestion begins + SemiAnalysis modest miss), tail -46% (multi-quarter capex pause or Taiwan incident). Probability-weighted return is approximately flat to slightly negative — not the +30–50% the bullish analyst suggests.
The market is overweighting the multiple compression signal while underweighting the working capital deterioration signal. Receivables +65% YoY on +85% revenue = DSO extending. Inventory +110% YoY = turns slowing. These are textbook cycle-peak indicators that historically lead revenue by 2–3 quarters. The "compressed forward multiple" is the public-facing story; the working capital deterioration is the leading edge of the private one.
The August 27 Q2 FY27 print is the single most important event. Everything else — Iran escalation, FOMC minutes, China policy, technical levels — is second-order. A beat-and-raise confirms the SemiAnalysis trajectory and unlocks 25–35% upside to $250–280. A print that is "good but not SemiConfirmation-good" produces an air pocket to $170–185. The asymmetry of the print itself is wider than the asymmetry of holding through it.
The bull thesis has structural merit — business quality is genuinely exceptional at 74% gross margins, 65% operating margins, 114% ROE, $96B FCF, and fortress balance sheet with $51B net cash — but the entry point requires SemiAnalysis delta validation to be a clear-cut buy. Forward P/E of 15.9x is real only if FY27 EPS hits ~$10+, not the $8.97 consensus. The setup is asymmetric but the asymmetry is less favorable than bulls acknowledge: a SemiConfirmation miss compresses the multiple to 18–20x on consensus EPS = -16% to -20% drawdown, while confirmation produces +25–35%. The market has asymmetrically priced in confirmation. The technical setup supports a tactical long (price above rising 200 SMA at $191.53, MACD bullish crossover below zero, Bollinger Band squeeze at $190–212, RSI recovered from 37 to 50) but the position should be sized for the binary outcome, not for "buy and hold through August." The macro environment is actively hostile (stagflation impulse, higher-for-longer rates, Iran escalation, housing -15.45%) and limits the multiple expansion that bulls are pricing. Insider selling of $407M in 30 days by Stevens + Huang's methodical 10b5-1 plan signals that the people with orderbook visibility are reducing exposure at $200+. The cleanest expression is to own a tactical long with August-dated puts — paying 1.5–2% of position size for convex downside protection through the print. This is not an aggressive long and not an outright short; it is a premium-priced catalyst trade with positive convexity on confirmation and bounded downside on miss. Accumulation adds only on confirmation above $215 with volume expansion; trimming on a rally to $220+ before print reduces gamma exposure. The position should be 3–5% net long for diversified institutional books, not the 5–8% the bull thesis implies.
| Variable | Bull Threshold | Bear Threshold |
|---|---|---|
| Q2 FY27 DC revenue | >$50B (SemiAnalysis-implied) | <$45B (consensus-ish) |
| Q2 FY27 EPS | >$2.00 | <$1.70 |
| Hyperscaler FY26 capex guidance | Holds or raises | Any cut |
| TSMC utilization | Sustained >95% | <85% |
| Forward P/E post-print | 22–25x | 18–20x |
The SemiConfirmation premium baked into forward 15.9x P/E. Bulls treat the multiple as "compressed" relative to the 22–40x historical range. Bears correctly note that the multiple is only compressed relative to consensus that includes SemiConfirmation — which is not consensus. The market is pricing in $10+ FY27 EPS without verification. A 10–15% miss on SemiAnalysis is a -16% to -20% stock move that the asymmetric forward multiple framing does not protect against.
Second-most mispriced: The durability of the 74% gross margin. Bulls treat it as structural moat. Bears correctly identify it as scarcity pricing that normalizes as TSMC Arizona scales. Margin compression of 200–400bps over 12–18 months is the base case, not the bull case.
Third-most mispriced: Customer concentration. The "broadening TAM" narrative (sovereign + enterprise + robotics) is incremental ($5–15B over 18 months), not transformational. Top 4 hyperscalers remain 40–45% of revenue, and any single one of them cutting capex 20% is a $10–15B revenue hit that the broadening TAM cannot offset in the relevant timeframe.
Exceptional. ~90%+ share of AI training accelerator market, 74% gross margins (luxury-goods tier), 65% operating margins, 114% ROE, $96B FCF, $51B net cash, $130B operating income against $259M interest expense. Asset-light fabless model with structural software lock-in (CUDA + Mellanox + Spectrum-X). The most economically attractive semiconductor business in the public markets.
Strong but with working-capital caveats. GAAP earnings are clean (no restatements, no goodwill inflation, no off-balance-sheet exposure). OCF/NI = 0.85x in FY26 is below historical ~0.95x norm, driven by receivables +65% YoY and inventory +110% YoY — the cycle-peak working capital pattern. SBC $6.4B (FY26) is dwarfed by $40B buybacks, so net dilution is currently negative. Earnings are real, but the cash conversion is starting to slip.
Exceptional but trending. FY26 FCF $96.7B; Q1 FY27 OCF $26B annualized = ~$104B run-rate. Capex intensity ~2.8% of sales (fabless model). Working capital consumed $27B in FY26, which reverses on any demand normalization — meaning FCF could spike higher in a digestion phase.
Structural-looking but cyclical-peak. 74% gross / 65% operating / 63% net reflects scarcity pricing on Blackwell. As TSMC Arizona scales 2027–2028 and HBM costs rise 20–30% on next-gen, GM likely compresses 200–400bps. Operating leverage at this scale means any revenue deceleration flows to GM faster than to revenue.
Strong but narrowing at the margins. CUDA + networking + systems + developer community is genuine and durable for training workloads. For inference, custom silicon (TPU, Trainium, Maia, Apple silicon) is gaining share. AMD ROCm has achieved ~80% PyTorch parity in 2026 (up from ~30% in 2023), reducing CUDA lock-in. The moat is real but is being progressively bypassed at the inference layer.
Fortress. Net cash $51.5B, debt $11B, current ratio 3.44x, quick ratio 2.14x. No covenant risk, no refinancing risk, no leverage stress. Could absorb a multi-year severe demand contraction without distress.
Exceptional execution, ambiguous capital signaling. Jensen Huang has delivered one of the greatest multi-decade wealth-creation records in tech history. Track record of under-promising and over-delivering on the AI thesis (FY24, FY25, FY26 guidance all beat by double-digit %). However, insider behavior at $200+ is signaling reduction: Stevens sold 885K shares June 18 + 1M shares June 4 ($407M cumulative), Huang has been a methodical 10b5-1 seller. This could be routine tax planning, but it is also what insiders do when they view current prices as full.
Disciplined but restrained. FY26 buybacks $40B, dividends $974M (negligible), M&A $1B (adjacent only). No leverage plays, no empire-building. The only critique is that with a $4.9T market cap, $40B buybacks is a rounding error; more aggressive capital return or a meaningful dividend initiation would be more shareholder-aligned. But the absence of M&A bloat and leverage is positive.
The business is genuinely exceptional. There is no other $4.9T company with this combination of margins, FCF, growth, and balance sheet. The "quality" classification is not in dispute. The debate is valuation and cycle timing, not business quality.
| Metric | Value | Interpretation |
|---|---|---|
| Price | $202.78 | 14% off $235.74 ATH |
| Trailing P/E | 31.1x | Compressed from peak |
| Forward P/E | 15.9x | 5th percentile of 3-yr range; SemiConfirmation-priced |
| EV/Sales TTM | 19.4x | High but justified by margins |
| EV/EBITDA TTM | 29.6x | Reasonable for hyper-growth |
| EV/FCF TTM | ~50x | Compressed vs historical ~80–100x |
| PEG | 0.6x | Depends on growth durability assumption |
| FCF Yield | ~1.0% | Compressed for hyper-growth |
| 52-Week Range | $161.61–$236.54 | Current 24% above low, 14% below high |
| Scenario | Probability | Implied Price | Return | Driver |
|---|---|---|---|---|
| SemiConfirmation Bull | 25% | $280 | +38% | SemiAnalysis delta + sovereign AI + China reopen |
| Base Case | 30% | $200 | -1% | Consensus holds, modest cycle digestion |
| Bear Case | 35% | $155 | -24% | SemiAnalysis modest miss + cycle digestion begins |
| Severe Bear | 10% | $110 | -46% | Multi-quarter capex pause + antitrust structural |
| Probability-weighted | — | ~$195 | -4% | Asymmetric downside skew |
SemiConfirmation is priced in, not perfection. Forward 15.9x P/E requires consensus EPS to hold at $8.97/$12.76 OR for SemiAnalysis delta to be true (which would expand earnings to $10+/$14+). The market is paying for one of two scenarios; both are within reach but neither is guaranteed. This is not perfection pricing — it is asymmetric confirmation pricing.
For forward 15.9x to be justified:
This is a 5-way conjunction of "good but not great" scenarios. The probability that all five materialize is reasonable (~50–60%) but not high enough to justify aggressive accumulation at $202.
The valuation is fair on consensus, attractive on SemiConfirmation, expensive on a SemiAnalysis miss. The current price is not a clear buy and not a clear sell; it is a conditional trade on the August 27 print.
70.8% — high but dispersed. The $1T market-cap correction reflects active manager deleveraging, not long-only core liquidation. Vanguard, BlackRock, State Street, Fidelity Contrafund have been stable through the drawdown.
Dispersed and mean-reverting. Positioning transitioned from crowded-long (early 2026) to cautious-neutral (mid-2026). Many fast-money funds stopped out above $230. Tactical funds are positioned to chase upside on SemiConfirmation. Smart money is hedged via Broadcom (AVGO) or SOXS.
Heavy but rational, not euphoric. Forward P/E of 15.9x is generating dip-buyer FOMO. The July 9 +1.18% close and 4.74% intraday move suggest reflexive dip-buying. No meme dynamics, no gamma squeeze setup.
1.24% of float, 1.72 days-to-cover — negligible. No squeeze vulnerability. Shorts have either covered or never established. The stock is structurally short-light, which means there is no mechanical short covering to fuel upside.
Elevated but not extreme. Beta 2.21 ensures heavy options activity. Implied vol elevated but compressible into earnings. Dealer short-gamma near $200–210 = knife-edge. A 5% move either direction could trigger cascading flows.
Healthy. ADV ~160M shares (~$32B turnover). Well above sector norm. No liquidity-fragility concern.
Sideways-to-down. 50-day MA at $209.24 is now resistance. 200-day MA at $191.53 is support. Bollinger Band squeeze (compression from $234.70 upper / $190.31 lower to current $212.54 / $190.31) signals imminent directional expansion.
Moderately bullish but cooling. Narrative shifted from "AI trade is unmissable" to "AI trade requires patience" — maturation, not rejection. Strategists calling for "pre-AI boom valuation" framing is a late-cycle sentiment indicator.
Complacent at the macro level. VIX 5th percentile of 52-wk range despite Iran Phase 2 escalation. VVIX 80–90 zone. Dealer short-gamma near $200–210 = asymmetric move risk. Vol regime shift probability 35–40% over 3 months.
Transitional. Was crowded-long in early 2026; is now cautious-neutral. Active managers are underweight relative to historical. Long-only core is stable. Positioning is not extreme in either direction, which means the reflexive flows on either side of the print are not pre-loaded.
Yes, on SemiConfirmation. A clean breakout above $215 with volume expansion could trigger:
Target: $235–250 on confirmed breakout. Probability: 55% on SemiConfirmation, 25% absent SemiConfirmation.
Yes, on SemiAnalysis miss. A close below $190 (lower Bollinger Band) with volume would trigger:
Target: $170–180 on breakdown. Probability: 35% on print miss, 15% absent SemiConfirmation issues.
At the macro level, yes. VIX at 5th percentile of 52-wk range despite Iran Phase 2 escalation, housing -15.45%, FOMC "family fight" framing = complacency. NVDA-specific positioning is not complacent; it is balanced.
No. The narrative is "AI trade requires patience," not "AI trade is unmissable." This is sentiment cooling, not overheating. Euphoria is not the current state; measured optimism is.
The positioning has been cleaned by the $1T drawdown. Active managers are no longer crowded-long. Long-only core is stable. The setup is neither extreme in either direction, which is a more favorable backdrop for a tactical catalyst trade than for a directional bet.
10Y at 4.56% (+0.22% MoM) — Rising. Fed funds at 3.63% unchanged. "Family fight" FOMC framing = internal dissent = hawkish tail risk. For NVDA specifically: Higher discount rates compress terminal value; hyperscaler capex is increasingly debt-funded (SOFR+ rates), making financing more expensive. A 100bps rise in 10Y (to 5.56%) compresses fair-value DCF by ~15–20% for a long-duration growth stock. This is the single most macro-relevant variable for NVDA's multiple.
M2 +1.09% — ample but slowing. Bank lending standards tightening. High-grade credit spreads elevated. Liquidity contraction would impair AI capex financing, which is increasingly debt-funded.
Elevated. Housing starts -15.45% MoM (sharp single-month drop), Real GDP +0.52% (expansion slowing), unemployment 4.2% (low but softening). A US recession would directly impair hyperscaler AI capex as ROI pressure intensifies. Probability: 25% over 12 months.
Elevated and asymmetric. FTC Frontier Model Forum inquiry (bundling/CUDA lock-in concerns), French competition authority probe (nearing conclusion), UK CMA, DOJ antitrust (Mellanox bundling). Worst-case structural remedy: forced CUDA unbundling + Mellanox divestiture = -20–30% earnings haircut. Probability: 15% over 12 months.
Structural, not tactical. BIS May 31, 2026 guidance extended license requirements to all D:5-headquartered entities "wherever located." Beijing refused to honor H200 imports despite valid BIS licenses. China revenue is permanently impaired ($50B annualized gap is explicit in management guidance). This is not a temporary disruption; it is the structural ceiling.
Low. Bipartisan pro-AI policy consensus. Mid-terms 10 months away. Neither party has incentive to relax export controls or pursue structural antitrust on NVDA. Election risk is lower than geopolitical risk.
Direct: not sanctioned. Indirect: enforcement risk elevated. $2.5B Supermicro smuggling indictment (March 2026) signals enforcement posture. Inadvertent third-country re-export violation risk.
Net positive. CHIPS Act, Section 232/301 tariffs, Defense Production Act, NATO AI investment. NVDA is the indirect beneficiary of US industrial policy even though subsidies flow to foundries.
Critical. NVDA's three sovereign dependencies:
Taiwan Strait kinetic event probability: 5–10% over 12 months. Impact: -40 to -60%. This is the single most material tail risk in the entire investment case.
Yes, in stagflation tail scenarios. If 10Y rises to 5%+ AND housing rollover accelerates AND Iran escalates to full Hormuz closure, the equity multiple compression overwhelms even SemiConfirmation. This is a low-probability but high-impact scenario.
Both. Strategically critical (US national security asset) + politically sensitive (too visible to attack). Inside the US-allied sphere, NVDA is a beneficiary of industrial policy. Outside (China), it is permanently impaired. The cleanest summary: NVDA is a Geopolitical Beneficiary inside the US-allied sphere, hostage to one chokepoint (TSMC Taiwan) and two great powers (US, China) that have weaponized compute access.
The macro environment is actively hostile to high-multiple growth: stagflation impulse (energy shock + housing weakness + slow growth), higher-for-longer rates ("family fight" FOMC), credit tightening, consumer weakness, geopolitical tail (Iran, Taiwan). Within this environment, NVDA is structurally resilient (fortress balance sheet, $96B FCF) but multiplicatively vulnerable (long-duration growth stock with 31x trailing P/E).
This is the single most important catalyst over the next 12 months. It is binary, asymmetric, and mechanically tied to the central valuation debate. A beat-and-raise with SemiConfirmation guidance validates the entire bull thesis and unlocks 25–35% upside. A print that is "good but not SemiConfirmation-good" produces an air pocket to $170–185. The market is asymmetrically priced for confirmation, so the asymmetry of the print itself is wider than the asymmetry of holding through it. Every other catalyst — Iran, FOMC, China policy, technical levels — is second-order to the print.
Probability: 25% Expected Stock Impact: +38% to ~$280
Key Assumptions:
Probability: 30% Expected Stock Impact: -1% to ~$200 (range-bound)
Key Assumptions:
Probability: 35% Expected Stock Impact: -24% to ~$155
Key Assumptions:
Probability: 10% Expected Stock Impact: -46% to ~$110
Key Assumptions:
Probability: 5% Expected Stock Impact: -61% to ~$80
Key Assumptions:
Probability-weighted return calculation:
The current price offers slight negative expected return with significant downside in the bear and tail scenarios. This is not a screaming buy or a screaming short; it is a conditional trade on the August 27 print with defined risk parameters.
Momentum: Sideways-to-down. 50 SMA at $209.24 is resistance; 200 SMA at $191.53 is support. Bollinger Band squeeze (compression from $234.70 to $212.54 upper band) signals imminent directional expansion.
Volatility: Elevated but compressible. Implied vol elevated into earnings. Realized vol 35–45% annualized.
Catalyst Timing: August 27 is the binary event. Pre-print positioning should focus on SemiConfirmation signals.
Positioning: Dealer short-gamma near $200–210. A move above $215 triggers gamma squeeze; a move below $190 triggers cascade.
Risk Management: 2× ATR stop = ~$14 from entry. Position size calibrated such that 1× ATR ($7) adverse move is tolerable.
Strategy: Mean-reversion within $190–212 range until catalyst. Breakout trade above $215 with volume confirmation = momentum long. Breakdown below $190 = momentum short. Sizing should reflect binary print outcome.
Tactical Entry Levels:
Sentiment Shifts: Monitor SemiAnalysis delta becoming consensus (positive), insider selling acceleration (negative), working capital signals in Q2 print (mixed), Iran escalation (negative), FOMC hawkish surprise (negative).
Catalyst Windows:
Strategy: Pre-print positioning with August-dated options. Long stock with August $190 puts for hedge (1.5–2% of position size). Sell into $215–220 resistance before print unless SemiConfirmation has materialized.
Accumulation Strategy:
Thesis Durability: Strong on business quality; weak on cycle timing. The 5–10 year compounding thesis is intact but the 12–24 month entry point is binary on the print.
Valuation Discipline: Don't pay more than 20–22x forward on consensus EPS ($8.97/$12.76) without SemiConfirmation. Willing to pay 25–28x on SemiConfirmation EPS ($10+/$14+).
Position Sizing:
The setup is an event-driven trade structured around the August 27 print. Long NVDA with August-dated $190 puts (1.5–2% of position size) provides:
This is not a momentum long (cycle is transitioning, not confirmed), not a high-conviction long (SemiConfirmation is not consensus), and not a tactical short (asymmetry favors hedge, not directional short). It is an event-driven catalyst trade with defined risk.
Bullish thesis invalidation:
Bearish thesis invalidation:
Bullish repositioning triggers:
Bearish repositioning triggers:
Asymmetric downside risk is highest at:
Asymmetric upside risk is highest at:
Position Sizing:
Stop-Loss Logic:
Hedging Ideas:
Options Strategies:
Exposure Limits:
Growth Portfolios: Suitable as core long-term holding with sizing discipline. Forward 16x P/E on 42% growth is institutionally attractive if execution holds. Position size 3–5%.
Value Portfolios: Marginally suitable. Forward 16x P/E + PEG 0.6 is value-tilted for a hyper-growth name, but the cycle risk and multiple compression history limit value-investor appeal.
Macro Funds: Suitable for tactical positioning around catalyst. Pair trade with energy/commodities exposure could hedge macro stagflation while maintaining AI exposure.
Momentum Funds: Currently challenged. Cycle is transitioning, not confirmed. Wait for breakout above $215 with volume before momentum re-engagement.
Long-Duration Portfolios: Suitable as core holding with sizing discipline. The 5–10 year compounding thesis is intact; the 12–24 month entry is binary on the print.
Tactical Trading Books: Highly suitable. Beta 2.21 + IV elevated + binary catalyst = textbook event-driven setup.
Sovereign Wealth Funds: Already accumulating at the dip. Suitable for strategic long-term position; "strategic asset" framing supports continued accumulation.
Retail Traders: Suitable for sophisticated retail with options knowledge. Direct long is acceptable for 5–10 year horizon; tactical positioning around print requires hedging discipline.
NVDA is not a core long-term holding at current price (SemiConfirmation-priced, not consensus-priced) and not a tactical short (asymmetry favors hedge over directional). It is a tactical growth exposure with hedge — sized for the binary August 27 print, with downside bounded by August-dated puts.
For portfolios that already hold NVDA as core: hold position, add modestly on weakness to $190–195, hedge with August $190 puts, trim 25% on miss.
For portfolios considering NVDA: wait for SemiConfirmation or weakness to $185–190 before initiating; do not chase at $202.
The clearest edge is that the market is treating forward 15.9x P/E as "compressed" when it is actually SemiConfirmation-priced. The multiple is only anomalous on consensus that includes SemiAnalysis's $203B H2 FY27 estimate — which is not consensus. A 10–15% miss on SemiAnalysis compresses the multiple to 18–20x on flatlining estimates = -16% to -20% drawdown. The market is asymmetrically positioned for confirmation, which creates a tactical opportunity to buy on confirmation (above $215 with volume) or hedge on miss (August $190 puts).
The market is conflating multiple compression on rising estimates (bullish) with multiple compression on decelerating demand (bearish). The current setup is the latter. Working capital is deteriorating (receivables +65% YoY, inventory +110% YoY = DSO extending, turns slowing), insider behavior is signaling (Stevens $407M + Huang 10b5-1), and macro is hostile (stagflation, higher-for-longer rates, Iran escalation, housing -15.45%). The 30% cycle drawdown probability over 12–24 months is materially underpriced.
Marginally. Forward 16x P/E on 42% growth is genuinely anomalous if execution holds, but the entry point requires SemiConfirmation to be clear-cut. At $202, the risk/reward is roughly balanced with slight downside skew. The opportunity becomes attractive at $185–190 (200 SMA retest) or above $215 (50 SMA reclaim with volume).
The Q2 FY27 print on August 27 is the single most important event. Everything else — Iran escalation, FOMC minutes, China policy, technical levels, hyperscaler capex guidance — is second-order. A beat-and-raise confirms the bull thesis and unlocks $250–280 target. A modest miss produces an air pocket to $170–185. The asymmetry of the print itself is wider than the asymmetry of holding through it.
Taiwan Strait kinetic event — single-source TSMC dependency is the single greatest tail risk in the entire investment case. Probability 5–10% over 12 months, impact -40–60%. This is uncorrelated with all other risks and cannot be diversified away. The market is treating this as a tail; the consequence is catastrophic. Second-biggest hidden risk: working capital deterioration is signaling cycle peak 2–3 quarters ahead of revenue deceleration. The first sign will be in the Q2 FY27 print.
Yes, but with hedge. Long NVDA at $202 with August-dated $190 puts (1.5–2% of position size) provides positive convexity on the binary outcome. The position is investable but not aggressive. Pure long without hedge is acceptable only for 5–10 year horizon investors willing to ride through the print and any subsequent digestion phase.
Event-driven trade with defined risk. Long NVDA + August $190 puts for the binary outcome. Position size 3–5% for diversified institutional books. Trim 25% on miss, add 25% on confirmation. Hold core through cycle, layer tactical adds on SemiConfirmation signals. Do not chase above $215; do not panic below $190 unless 200 SMA fails with volume.
Bullish view upgrade triggers:
Bearish view downgrade triggers:
(Business quality conviction: Very High. Near-term price action: Medium. Multi-year compounding: Very High. Catalyst probability: Medium-High. Hedge required for binary outcome.)
(Asymmetric on confirmation to upside, asymmetric on miss to downside. Net probability-weighted return ~-4%, but bounded by hedge. Best-case +38% with SemiConfirmation, worst-case -46% with multi-quarter capex pause, base case -1% range-bound.)
The trade is structured around the August 27 print as event-driven catalyst. The underlay is the 5–10 year compounding thesis (CUDA + ecosystem + sovereign AI + physical AI). Tactical adds on SemiConfirmation, trims on miss, but core holding through the cycle.
End of Report — Next update upon Q2 FY27 print (Aug 27, 2026), Iran policy development, or material Taiwan geopolitical escalation.